Aevi Genomic Med

GNMX NASDAQ
0.1857
-0.0128
-6.45%
盘后: 0.1970 +0.0113 +6.09% 17:48 07/19 EDT
开盘
0.1900
昨收
0.1985
最高
0.1975
最低
0.1800
成交量
68.07万
成交均量(3M)
127.66万
52周最高
1.400
52周最低
0.1500
换手率
1.05%
市值
1,202.72万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Aevi Genomic Med GNMX股票价格,Aevi Genomic Med股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Aevi Genomic Medicine, Inc., formerly Medgenics, Inc., is focused on genomic medicine. The Company is engaged in unlocking the potential of genomic medicine to translate genetic discoveries into therapies. The Company is engaged in developing therapies for children and adults with pediatric onset life altering diseases. The Company's product candidates include AEVI-001 and AEVI-002. The Company's research and development efforts leverage an internal genomics platform and a collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). .
展开 >

最近浏览

名称
价格
涨跌幅